Group One Trading
NUVB icon

Group One Trading’s Nuvation Bio NUVB Stock Holding History

Group One Trading’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
277,400
+39,300
+17% +$192K ﹤0.01% 2450
2026
Q1 		$1.02M Buy
238,100
+124,700
+110% +$695K ﹤0.01% 2701
2025
Q4 		$1.02M Buy
113,400
+33,300
+42% +$206K ﹤0.01% 2873
2025
Q3 		$296K Sell
80,100
-350,200
-81% -$954K ﹤0.01% 4240
2025
Q2 		$839K Buy
430,300
+74,800
+21% +$156K ﹤0.01% 2926
2025
Q1 		$626K Buy
+355,500
New +$809K ﹤0.01% 2873
2021
Q3 		– Sell
-6,000
Closed -$56K – 8587
2021
Q2 		$56K Buy
+6,000
New +$68.4K ﹤0.01% 6473

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Group One Trading's NUVB Position: Q2 2026 in Review

Group One Trading increased its Nuvation Bio (NUVB) stake by 178% in Q2 2026, buying an estimated $618K and bringing the position to 197,470 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2757.

Group One Trading first reported a position in NUVB in Q2 2021 and has held it in 8 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Group One Trading held 197,470 shares of Nuvation Bio worth $1.12M as of Q2 2026.
  • Group One Trading bought 126,389 Nuvation Bio shares in Q2 2026, an estimated $618K.
  • Nuvation Bio made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #2757 holding.
  • Group One Trading first reported a position in Nuvation Bio in Q2 2021 and has held it in 8 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.